Evidence map›Paper›PMID 36421293›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Successful Control of an Outbreak by Phenotypically Identified Extended-Spectrum Beta-Lactamase-Producing

Elena Priante, Chiara Minotti, Cristina Contessa, Margherita Boschetto, Paola Stano, Federico Dal Bello, Ettore De Canale, Elisabetta Lolli, Vincenzo Baldo, Eugenio Baraldi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Risk factors associated with extended spectrum beta lactamaseAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Elena PrianteNeonatal Intensive Care Unit, Department of Women's and Children's Health, University Hospital of Padua, 35128 Padova, Italy.
Chiara MinottiNeonatal Intensive Care Unit, Department of Women's and Children's Health, University Hospital of Padua, 35128 Padova, Italy.ORCID 0000-0003-3941-9952
Cristina ContessaDepartment of Directional Hospital Management, University Hospital of Padua, 35128 Padova, Italy.
Margherita BoschettoDepartment of Directional Hospital Management, University Hospital of Padua, 35128 Padova, Italy.
Paola StanoMicrobiology and Virology Unit, University Hospital of Padua, 35128 Padova, Italy.
Federico Dal BelloMicrobiology and Virology Unit, University Hospital of Padua, 35128 Padova, Italy.
Ettore De CanaleMicrobiology and Virology Unit, University Hospital of Padua, 35128 Padova, Italy.
Elisabetta LolliNeonatal Intensive Care Unit, Department of Women's and Children's Health, University Hospital of Padua, 35128 Padova, Italy.
Vincenzo BaldoInfection Control Division, University Hospital of Padua, 35128 Padova, Italy.ORCID 0000-0001-6012-9453
Eugenio BaraldiNeonatal Intensive Care Unit, Department of Women's and Children's Health, University Hospital of Padua, 35128 Padova, Italy.
Daniele DonàDivision of Pediatric Infectious Diseases, Department of Women's and Children's Health, University Hospital of Padua, 35128 Padova, Italy.ORCID 0000-0001-7105-2105
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPremature newborns represent a vulnerable population, at high risk of acquiring nosocomial infections during neonatal intensive care unit (NICU) admission. Multidrug-resistant organisms represent the greatest concern due to their intrinsic virulence and the limited therapeutic options. Resistant

resultsA total of 13 newborns tested positive for ESBL-KP between 2-9 February 2021, of whom four (31%) had a bloodstream infection. Two were critically ill, extremely premature newborns who died because of multiple comorbidities, and two were cured after treatment with meropenem. All other patients survived and were either discharged home or moved to other hospitals/wards in good clinical condition. ESBL-KP ST45 was found in all isolates by multilocus sequence typing (MLST) analysis. An outbreak control plan was set, including surveillance cultures for all neonates, NICU environments, and medical devices, along with the extended use of contact precautions and cohorting. In addition, the infection control plan was carried out through reinforcement and enhancement measures to guarantee maximal compliance. The outbreak was successfully controlled in seven days, given that no further cases were identified after 9 February. The source of the ESBL-KP outbreak was not identified through environmental sampling.

conclusionsThanks to multidisciplinary management, a threatening outbreak of ESBL-KP in a NICU was controlled in few days. The prompt recognition of the event onset and the adoption of infection control interventions helped contain the bacteria spread on the ward.

Indexed as

extended-spectrum beta-lactamase-producing Klebsiella pneumoniaemultidrug-resistant organismneonatal intensive care unitnewbornoutbreak

Identifiers

PMID36421293
PMCPMC9686647
OpenAlexW4309463286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.